BAYRY News and Press, Bayer AG ADR From 05/11/22

The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2022 Q1 earnings call. For further details see: Bayer Aktiengesellschaft 2022 Q1 - Results - Earnings Call Presentation

Bayer (OTCPK:BAYRY) falls more than 7% in Europe on Wednesday after a U.S. Department of Justice brief recommended the Supreme Court reject the company's appeal to review a case linking its Roundup weedkiller to a type of cancer. Jefferies analysts say the DoJ's brief reduces the likelihood o...

Bayer's defensive business mix, along with prodding for change from an activist investor, seemed to catalyze the stock's outperformance during Q1 2022. Mittleman Investement Management (MIM) hasn't owned a large cap pharmaceutical company since a very successful foray into Pfizer just...

Mittleman Investment Management, LLC (“MIM”) is an SEC-registered investment adviser that provides discretionary portfolio management to institutional investors and high-net-worth individuals. The Mittleman Global Value Equity Fund (MGVEF) declined 13.1% in Q1 2022. ...

The Department of Justice is siding with the plaintiff as Bayer (OTCPK:BAYRY) goes to the U.S. Supreme Court to try to stop potentially billions of dollars in claims that its Roundup weedkiller causes cancer, Bloomberg reported Tuesday. Bayer (OTCPK:BAYRY) is challenging a $25M award to a Cal...

Bayer Aktiengesellschaft (BAYZF) Q1 2022 Results Conference Call May 10, 2022 08:00 AM ET Company Participants Oliver Maier - Head, IR Werner Baumann - CEO Wolfgang Nickl - CFO Rodrigo Santos - President, the Crop Science Division Stefan Oelrich - Head, the Pharmaceuticals Division Conference...

Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) Q1 revenue grew on the back of sales of its Agriculture segment, and the company maintained its FY22 outlook. The German conglomerate's core EPS grew +36.3% Y/Y to $3.53. Net income (including discontinued operations) grew +57.5% to ~€3.29B. Gro...

The war in Ukraine continues to dominate market movements. I have started exiting one of my apartment REITs and predominantly focus on adding dividend income via select purchases. The combination of soaring inflation and geopolitical uncertainty has rattled markets and following t...

We allocated 3% of the portfolio to Siemens Energy AG. SMEGF has the opportunity to leverage several significant trends over the coming years. We hope to build to a 6% position in due time but think that the market may give us an opportunity to buy cheaper. For further detai...

German conglomerate Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) announced on Tuesday that the U.S. Food and Drug Administration (FDA) granted the priority review and accepted its supplemental New Drug Application ((sNDA)) for prostate cancer therapy Nubeqa. With the sNDA, Bayer (OTCPK:BAYRY) has reques...